4221 - 4230 of 7939 Results
Title
Year
-
OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 503End Page: 512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25824Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719613Citation Count: 84
- Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset2020OPENTitle: Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease OnsetJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1346End Page: 1356Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28144Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28144Citation Count: 30
-
OPENTitle: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00524Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00524/pdfCitation Count: 28
-
OPENTitle: Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approachJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00388-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00388-2Citation Count: 54
-
RESTRICTEDTitle: Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.007Citation Count: 43
- Enhancing convolution-based sentiment extractor via dubbed N-gram embedding-related drug vocabulary2020OPENTitle: Enhancing convolution-based sentiment extractor via dubbed N-gram embedding-related drug vocabularyJournal Name: Network Modeling Analysis in Health Informatics and BioinformaticsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13721-020-00248-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13721-020-00248-5.pdfCitation Count: 9
-
RESTRICTEDTitle: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&DJournal Name: Research PolicyPublisher: Elsevier BVVol: 49Issue #: 8Start Page: 104032End Page: 104032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032Citation Count: 3
-
OPENTitle: Identifying and predicting Parkinson’s disease subtypes through trajectory clustering via bipartite networksJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 6Start Page: e0233296End Page: e0233296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0233296Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233296&type=printableCitation Count: 22
-
RESTRICTEDTitle: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00577Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00577/pdfCitation Count: 51
-
RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 94